Navigation Menu is only visible when JavaScript is enabled
American Society of Human Genetics - San Diego - October 18-22, 2014 Contact Search
 

Abstracts

 
  Speaker Guidelines
  Abstract Assignments
   




ACCME Accreditation Requirements and Guidelines

 

 

The ASHG Annual Meeting has been planned and implemented in accordance with the requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American College of Medical Genetics and Genomics (ACMG) and ASHG. The ACMG is accredited by the ACCME to provide continuing medical education for physicians.

All educational programming is developed and must be presented in compliance with all ACCME accreditation requirements. As you prepare your presentation, please keep these thoughts in mind.

 

Disclosure Statement

In accordance with the Accreditation Council for Continuing Medical Education and the policy of the American College of Medical Genetics, all individuals responsible for the content of this program have disclosed the existence of any financial interest and/or other relationship(s) they might have with any manufacturer(s) or provider(s) of any commercial product(s) or service(s) discussed in this program: receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities for which remuneration is received or expected. 

 

Content Validation and Fair Balance

  • ACMG follows the ACCME policy on Content Validation for CME activities, which requires:
    • All recommendations involving clinical medicine must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients.
    • All scientific research referred to, reported or used in CME in support or justification of patient care recommendations must conform to the generally accepted standards of experimental design, data collection and analysis.
  • Activities that fall outside the definition of CME/CE; “Educational activities that serve to maintain, develop, or increase the knowledge, skills, and professional performance and relationships that a physician uses to provide services for patients, the public, or the profession” (source: ACCME and AMA) will not be certified for credit. CME activities that promote recommendations, treatment, or manners of practicing medicine or pharmacy that are not within the definition of CME/CE or, are known to have risks or dangers that outweigh the benefits or, are known to be ineffective in the treatment of patients.
  • Presentations and CME/CE activity materials must give a balanced view of therapeutic options; use of generic names will contribute to this impartiality.  If the CME/CE educational materials or content includes trade names, where available, trade names from several companies must be used.

Presentation Preparation

  • Talks must be free of commercial bias for or against any product. If commercial products are discussed, the session must present objective information about those products, based on generally accepted scientific evidence. Speakers must not engage in the marketing of their product(s) in any way during the presentation. Moderators have been instructed to intervene if this occurs.
  • The content or format of a CME activity or its related materials must promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial entity. Presentations must give a balanced view of therapeutic options. Use of generic names will contribute to this impartiality. If the educational material or content includes trade names, trade names from several companies should be used when available, not just trade names from a single company. 
  • All speakers must sign a disclosure statement regarding the existence of any financial interest and/or other relationship(s) they might have with the manufacturer(s) or provider(s) of any commercial product(s) or service(s) or with commercial and academic laboratories that accept samples for testing or develop any laboratory test or test(s) to be discussed during your presentation. Platform presenters completed this disclosure during the abstract process. Invited presenters completed this disclosure through a web link sent by the ASHG office.
  • If you have indicated such a relationship, you may be contacted by a member of the Program Committee to request peer review of your presentation. Disclosure of financial relationships will be listed in the Program.
  • Authors must include a conflict-of-interest slide as part of their presentations to meet ACCME requirements, even when there is nothing to disclose. This ASHG-approved slide will be inserted automatically as the first slide in the presentation. If you indicated a conflict, the disclosure information you completed during your abstract submission will be used automatically. No further action is required by authors for the conflict-of-interest slide.

 

 

Contact Meeting Management

 

The American Society of Human Genetics, Incorporated | 9650 Rockville Pike, Bethesda, Maryland 20814
society@ashg.org 1-866-HUM-GENE (301) 634-7300
Privacy Policy